First-in-human, first-in-class study of the CD44v6 inhibitor AMC303 as monotherapy in patients with advanced epithelial tumors

Authors :: Emiliano Calvo
Angela Martín
Analia Azaro
Paolo Nuciforo
M.J. de Miguel
P. Ehmer
K. Dembowsky
Christiane Jungels
H.K. Bender
J. Zeron-Medina Cuairan
Philippe Aftimos
Source :: Annals of Oncology. 29:viii134
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
Hematology
First in human
Class (biology)
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
business

Tools